Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Average Rating of “Moderate Buy” from Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $92.80.

A number of brokerages recently issued reports on MMSI. Piper Sandler cut their price objective on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Robert W. Baird set a $83.00 price objective on Merit Medical Systems in a research report on Friday, May 1st. Wall Street Zen downgraded Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 5th. JPMorgan Chase & Co. cut their price objective on Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Compass Point set a $107.00 price objective on Merit Medical Systems in a research report on Monday, April 20th.

Merit Medical Systems Stock Up 3.0%

Shares of NASDAQ:MMSI opened at $67.22 on Friday. The business has a 50-day moving average price of $65.49 and a 200 day moving average price of $74.76. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $4.01 billion, a price-to-earnings ratio of 29.10, a PEG ratio of 2.03 and a beta of 0.54. Merit Medical Systems has a 12-month low of $59.74 and a 12-month high of $96.74.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company earned $0.86 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts expect that Merit Medical Systems will post 3.62 EPS for the current year.

Insider Activity

In other Merit Medical Systems news, Director Lynne N. Ward sold 5,000 shares of Merit Medical Systems stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $62.61, for a total value of $313,050.00. Following the completion of the transaction, the director directly owned 7,809 shares of the company’s stock, valued at $488,921.49. The trade was a 39.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Brian G. Lloyd bought 2,000 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was purchased at an average cost of $62.62 per share, with a total value of $125,240.00. Following the completion of the transaction, the insider owned 2,000 shares in the company, valued at $125,240. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Merit Medical Systems

Several institutional investors have recently bought and sold shares of MMSI. Los Angeles Capital Management LLC acquired a new position in Merit Medical Systems in the 4th quarter valued at about $25,000. Maseco LLP acquired a new position in Merit Medical Systems in the 4th quarter valued at about $26,000. Torren Management LLC acquired a new position in Merit Medical Systems in the 4th quarter valued at about $38,000. Covestor Ltd grew its position in Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares in the last quarter. Finally, Danske Bank A S acquired a new position in Merit Medical Systems in the 3rd quarter valued at about $42,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.